Skip to main content

Table 4 Patients studied – site of infection

From: A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

Site of infection Total no. of patients in this category Number of patients suitable for switch to oral therapy (% of patients with this site of infection) Number of patients suitable for switch to oral therapy and early discharge (% of patients with this site of infection)
Blood 40 8 (20%) 3 (8%)
Sputum 40 2 (5%) 2 (5%)
Skin/Soft tissue 118 77 (65%) 54 (46%)
Other 13 6 (46%) 3 (23%)
Total 211 93 62